H.R. 478 · 116th Congress
Safe and Affordable Drugs from Canada Act of 2019
- Stage
- In committee
- Sponsor
- Chellie Pingree
- Introduced
- 2019-01-10
- Latest action
- 2019-01-25 · Referred to the Subcommittee on Health.
Summary
Safe and Affordable Drugs from Canada Act of 2019
This bill requires the Food and Drug Administration (FDA)to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug
is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.